The reasons for these misclassifications were MRI signal changes that were atypical for an IDH-wildtype glioblastoma (Figure 6) and susceptibility artifacts due to bleeding in the IDH-mutated oligodendroglioma WHO grade 3 (Figure 7), respectively. The gene discussed is IDH2; the disease is oligodendroglioma.